INVO Bioscience (INVO) Reports Q1 results

INVO Bioscience (NASDAQ: INVO) reported Q1 revenue for the quarter at $278.14 thousand versus the consensus estimate of $257.5 thousand.

For earnings history and earnings-related data on INVO Bioscience (INVO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• Citi upgrades Bath & Body Works to Buy with $25 price target